Makes silicone gel-filled breast implants for aesthetic and reconstruction surgeries.
Jun 2026Revenue $246M/yrExpenses $265M/yr
No trendCash runway ≈ 1.7 years from Jun 2026
Figures by year
When will Establishment Labs Holdings be profitable?
Its figures don’t show a steady enough trend to project a date. In the 12 months to Jun 2026, revenue was $246M and expenses $265M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2025 | $211M | $250M | −$39.0M |
| Dec 2024 | $166M | $216M | −$50.0M |
| Dec 2023 | $165M | $230M | −$65.0M |
| Dec 2022 | $162M | $201M | −$39.7M |
| Dec 2021 | $127M | $152M | −$25.1M |
| Dec 2020 | $84.7M | $113M | −$27.9M |
| Dec 2019 | $89.6M | $121M | −$30.9M |
| Dec 2018 | $61.2M | $85.1M | −$23.9M |
| Dec 2017 | $34.7M | $54.7M | −$20.0M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.